The rapid rise in Semaglutide's value has become a growing concern for patients . Originally marketed for diabetes , its popularity as a slimming aid has fueled dramatic rate hikes. Several factors are contributing this situation , including widespread adoption, constrained availability , manufacturer pricing , and the complexities of the drug indu